Clinical Trial Update: IMP4297 in Combination With Temozolomide in Patients With Advanced Solid Tumors and Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

IMP4297 combined with temozolomide was studied in patients with advanced solid tumors and small cell lung cancer in Phase 1/Phase 2 trials, and the study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer
• Solid Tumors

Drugs mentioned

• IMP4297 (IMP4297)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Impact Therapeutics, Inc. | Conditions: Advanced Solid Tumours, Small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED